Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Retrospective cohort study of 216 newly diagnosed AL amyloidosis patients demonstrating that limited dexamethasone (≤3 months) achieves similar overall response rates with faster deep hematologic response and reduced toxicity compared to prolonged exposure, with multivariable adjustment for confounding.
This is a narrative review proposing mechanistic connections between insulin resistance and cancer, with speculative discussion of monoclonal antibody therapeutics, but no primary experimental or clinical data to support efficacy claims.
A narrative review synthesizing current knowledge on dengue therapeutics (vaccines, antivirals, monoclonal antibodies) without original data or systematic analysis, offering translational context on development stage and mechanistic insight for clinical and research audiences.